Expert consensus on radiotherapy for oligometastatic esophageal cancer (2025 edition)
Approximately 40% of esophageal cancer patients have metastatic disease at the time of initial diagnosis. Although immunotherapy has changed the treatment pattern of advanced, recurrent, or metastatic esophageal cancer, the options for systemic treatment for these patients are still limited, and the...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Radiation Medicine and Protection |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666555725000486 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic impact of body composition and immune-nutritional status in oligometastatic NSCLC patients receiving radiotherapy
by: Zhifei Huang, et al.
Published: (2025-07-01) -
Effects of different treatments on the prognosis of patients with single-organ oligometastasis of esophageal cancer after surgery–a retrospective single center study
by: Jinrui Xu, et al.
Published: (2025-03-01) -
Practical management of oligometastatic gastric cancer
by: Y. Narita, et al.
Published: (2024-12-01) -
A spectacular tumor response of a giant axillary mass treated with SABR in a palliative scenario
by: Fernando Kojo Matsuura, et al.
Published: (2021-10-01) -
Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer
by: Gen Lin, et al.
Published: (2025-06-01)